Creative Biolabs-Immuno-oncology

Anti-CD7 (clone TH6Z9Q) SynExpress C-G-I10-X Modified CD8+ T cells (CAT#: ITS-1224-CR1732)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD7 (clone TH6Z9Q). We employs the pGEM (CMV-GFP-IL-10-XbaI) vector components and the SynExpress system of the Exons RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD7
Clone
TH6Z9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
IL-10
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.92
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.